
    
      Multicenter, randomized, double-blind parallel groups comparing adult patients with suspected
      invasive candidiasis input from a 14-day empirical treatment with micafungin (MYCAMINE 100
      mg) with placebo on survival without invasive candidiasis in 28 days after initiation of
      study treatment.
    
  